DRUG
Bright Minds Biosciences Inc.
Price Chart
No historical data available
Latest Quote
$73.02
-1.52 (-2.03%)
Current Price
| Previous Close | $74.53 |
| Open | $74.32 |
| Day High | $74.32 |
| Day Low | $72.50 |
| Volume | 15,356 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 9.81M |
| Total Debt | $47K |
| Cash Equivalents | $221.44M |
| Net Income | $-17.63M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $714.42M |
| EPS (TTM) | $-1.99 |
| Exchange | NCM |
Recent Price History
No history data available. Data will be fetched automatically.
About Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company's BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
đ° Latest News
No news articles available at the moment. Check back later for updates on DRUG.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $10,035,992 | $2,032,581 | $5,318,712 | $10,783,067 |
| Other Income Expense | $135,926 | $-6,705 | $10,217 | $7,309 |
| Net Non Operating Interest Income Expense | $1,094,119 | $21,698 | $0 | $0 |
| Operating Expense | $10,035,992 | $2,032,581 | $5,318,712 | $10,783,067 |
| Other Operating Expenses | $207,124 | $141,987 | $134,401 | $175,033 |
| Selling And Marketing Expense | $309,383 | $29,955 | $85,989 | $397,379 |
| General And Administrative Expense | $1,537,897 | $1,010,953 | $1,498,028 | $1,439,566 |
| Other Non Operating Income Expenses | - | - | - | $-175,033 |
| Total Other Finance Cost | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Net Interest Income | $1,094,119 | $21,698 | $0 | $0 |
| Interest Income | $1,094,119 | $21,698 | $0 | $0 |
| Normalized Income | $-8,941,874 | $-2,010,883 | $-5,318,712 | $-10,783,067 |
| Net Income From Continuing And Discontinued Operation | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Net Income Common Stockholders | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Net Income | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Net Income Including Noncontrolling Interests | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Net Income Continuous Operations | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Pretax Income | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Interest Income Non Operating | $1,094,119 | $21,698 | $0 | $0 |
| Operating Income | $-10,035,992 | $-2,032,581 | $-5,318,712 | $-10,783,067 |
| Special Income Charges | - | $0 | $0 | $-1,440 |
| Per Share | ||||
| Diluted EPS | $-1.28 | $-0.47 | $-1.43 | $-4.36 |
| Basic EPS | $-1.28 | $-0.47 | $-1.43 | $-4.36 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-10,116,568 | $-1,973,054 | $-5,276,760 | $-10,786,030 |
| Total Unusual Items | $135,926 | $-6,705 | $10,217 | $7,309 |
| Total Unusual Items Excluding Goodwill | $135,926 | $-6,705 | $10,217 | $7,309 |
| Reconciled Depreciation | $55,350 | $52,822 | $52,169 | $4,347 |
| EBITDA (Bullshit earnings) | $-9,980,642 | $-1,979,759 | $-5,266,543 | $-10,778,720 |
| EBIT | $-10,035,992 | $-2,032,581 | $-5,318,712 | $-10,783,067 |
| Diluted Average Shares | $4,952,657 | $3,103,609 | $2,678,487 | $1,778,841 |
| Basic Average Shares | $4,952,657 | $3,103,609 | $2,678,487 | $1,778,841 |
| Diluted NI Availto Com Stockholders | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Gain On Sale Of Security | $135,926 | $-6,705 | $10,217 | $8,750 |
| Research And Development | $7,981,587 | $849,686 | $3,600,294 | $8,771,090 |
| Selling General And Administration | $1,847,280 | $1,040,908 | $1,584,017 | $1,836,945 |
| Other Gand A | $1,179,804 | $655,389 | $665,254 | $1,367,964 |
| Salaries And Wages | $358,094 | $355,564 | $832,774 | $71,602 |
| Impairment Of Capital Assets | - | $0 | $0 | $1,440 |
Fetched: 2026-08-28
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $59,077,829 | $3,986,537 | $4,751,157 | $7,591,313 |
| Total Assets | $60,789,152 | $4,395,722 | $4,953,392 | $8,703,436 |
| Total Non Current Assets | $80,624 | $84,722 | $47,822 | $99,991 |
| Current Assets | $60,708,527 | $4,311,000 | $4,905,570 | $8,603,446 |
| Prepaid Assets | $711,362 | $155,987 | $19,940 | $118,400 |
| Receivables | $297,439 | $36,165 | $26,629 | $112,171 |
| Taxes Receivable | $151,155 | $36,165 | $26,629 | $82,461 |
| Accrued Interest Receivable | $146,284 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $59,699,727 | $4,118,849 | $4,859,001 | $8,372,875 |
| Cash And Cash Equivalents | $59,699,727 | $4,118,849 | $4,859,001 | $8,372,875 |
| Cash Equivalents | $62,106 | $62,106 | $62,106 | $62,106 |
| Cash Financial | $59,637,621 | $4,056,743 | $4,796,895 | $8,310,769 |
| Goodwill And Other Intangible Assets | - | - | - | $0 |
| Other Receivables | - | - | - | $29,711 |
| Debt | ||||
| Total Debt | $90,568 | $85,659 | $52,960 | $100,745 |
| Long Term Debt And Capital Lease Obligation | $29,702 | $28,497 | $0 | $51,833 |
| Current Debt And Capital Lease Obligation | $60,866 | $57,162 | $52,960 | $48,913 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,711,322 | $409,184 | $202,235 | $1,112,123 |
| Total Non Current Liabilities Net Minority Interest | $29,702 | $28,497 | $0 | $51,833 |
| Current Liabilities | $1,681,620 | $380,687 | $202,235 | $1,060,291 |
| Payables And Accrued Expenses | $1,620,755 | $323,525 | $149,275 | $1,011,378 |
| Payables | $1,231,523 | $293,462 | $131,273 | $897,480 |
| Accounts Payable | $1,231,523 | $293,462 | $131,273 | $897,480 |
| Equity | ||||
| Common Stock Equity | $59,077,829 | $3,986,537 | $4,751,157 | $7,591,313 |
| Total Equity Gross Minority Interest | $59,077,829 | $3,986,537 | $4,751,157 | $7,591,313 |
| Stockholders Equity | $59,077,829 | $3,986,537 | $4,751,157 | $7,591,313 |
| Gains Losses Not Affecting Retained Earnings | $3,869,209 | $2,884,853 | $2,447,577 | $1,785,381 |
| Retained Earnings | $-33,539,502 | $-24,733,554 | $-22,715,965 | $-17,407,471 |
| Other Equity Interest | - | $328,043 | $598,976 | - |
| Other | ||||
| Ordinary Shares Number | $5,498,279 | $3,257,645 | $2,716,144 | $2,533,534 |
| Share Issued | $5,498,279 | $3,257,645 | $2,716,144 | $2,533,534 |
| Tangible Book Value | $59,077,829 | $3,986,537 | $4,751,157 | $7,591,313 |
| Invested Capital | $59,077,829 | $3,986,537 | $4,751,157 | $7,591,313 |
| Working Capital | $59,026,907 | $3,930,313 | $4,703,335 | $7,543,155 |
| Capital Lease Obligations | $90,568 | $85,659 | $52,960 | $100,745 |
| Total Capitalization | $59,077,829 | $3,986,537 | $4,751,157 | $7,591,313 |
| Capital Stock | $88,748,123 | $25,507,195 | $24,420,569 | $23,213,403 |
| Common Stock | $88,748,123 | $25,507,195 | $24,420,569 | $23,213,403 |
| Long Term Capital Lease Obligation | $29,702 | $28,497 | $0 | $51,833 |
| Current Capital Lease Obligation | $60,866 | $57,162 | $52,960 | $48,913 |
| Current Accrued Expenses | $389,231 | $30,064 | $18,002 | $113,898 |
| Net PPE | $80,624 | $84,722 | $47,822 | $99,991 |
| Gross PPE | $80,624 | $84,722 | $47,822 | $99,991 |
| Leases | $80,624 | $84,722 | $47,822 | $99,991 |
| Properties | $0 | $0 | $0 | $0 |
| Other Properties | - | - | - | $99,991 |
Fetched: 2026-08-28
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-6,258,547 | $-1,332,258 | $-5,057,940 | $-9,783,632 |
| Operating Activities | ||||
| Operating Cash Flow | $-6,258,547 | $-1,332,258 | $-5,057,940 | $-9,783,632 |
| Cash Flow From Continuing Operating Activities | $-6,258,547 | $-1,332,258 | $-5,057,940 | $-9,783,632 |
| Operating Gains Losses | $-225,156 | $-7,291 | $32,654 | $-186,371 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $59,115,734 | $648,060 | $876,681 | $2,905,386 |
| Financing Cash Flow | $61,614,314 | $583,666 | $1,576,720 | $3,741,604 |
| Cash Flow From Continuing Financing Activities | $61,614,314 | $583,666 | $1,576,720 | $3,741,604 |
| Net Other Financing Charges | $-259,323 | - | $-19,425 | $-576,038 |
| Net Common Stock Issuance | $59,115,734 | $648,060 | $876,681 | $2,905,386 |
| Common Stock Issuance | $59,115,734 | $648,060 | $876,681 | $2,905,386 |
| Other | ||||
| Repayment Of Debt | $-72,115 | $-64,612 | $-62,006 | $-5,157 |
| End Cash Position | $59,699,727 | $4,118,849 | $4,859,001 | $8,372,875 |
| Beginning Cash Position | $4,118,849 | $4,859,001 | $8,372,875 | $14,228,532 |
| Effect Of Exchange Rate Changes | $225,111 | $8,439 | $-32,654 | $186,371 |
| Changes In Cash | $55,355,767 | $-748,592 | $-3,481,220 | $-6,042,028 |
| Proceeds From Stock Option Exercised | $2,830,018 | $217 | $781,470 | $1,417,413 |
| Net Issuance Payments Of Debt | $-72,115 | $-64,612 | $-62,006 | $-5,157 |
| Net Long Term Debt Issuance | $-72,115 | $-64,612 | $-62,006 | $-5,157 |
| Long Term Debt Payments | $-72,115 | $-64,612 | $-62,006 | $-5,157 |
| Change In Working Capital | $399,633 | $28,668 | $-678,101 | $521,424 |
| Change In Payables And Accrued Expense | $1,216,282 | $174,250 | $-862,103 | $551,563 |
| Change In Prepaid Assets | $-555,375 | $-136,047 | $98,460 | $2,720 |
| Change In Receivables | $-261,274 | $-9,536 | $85,543 | $-32,859 |
| Other Non Cash Items | $25,815 | $6,441 | $14,221 | $21,187 |
| Stock Based Compensation | $2,291,759 | $604,691 | $829,611 | $630,099 |
| Depreciation Amortization Depletion | $55,350 | $52,822 | $52,169 | $4,347 |
| Depreciation And Amortization | $55,350 | $52,822 | $52,169 | $4,347 |
| Depreciation | $55,350 | $52,822 | $52,169 | $4,347 |
| Net Foreign Currency Exchange Gain Loss | $-225,156 | $-7,291 | $32,654 | $-186,371 |
| Net Income From Continuing Operations | $-8,805,948 | $-2,017,588 | $-5,308,495 | $-10,775,758 |
| Asset Impairment Charge | - | $0 | $0 | $1,440 |
| Change In Other Current Liabilities | - | - | - | $1,565 |
Fetched: 2026-08-28